Nonpharmacological interventions for managing respiratory symptoms in lung cancer

Chronic Respiratory Disease

Volumn 9, Issue 2, 2012, Pages 117-129

  Yorke, Janelle ^a   Brettle, Alison ^a   Molassiotis, Alex ^b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

breathlessness; complementary therapies; cough; Lung cancer; nonpharmacological interventions

Indexed keywords

BREATHING DISORDER; CANCER THERAPY; CONSERVATIVE TREATMENT; COUGHING; DYSPNEA; HEMOPTYSIS; HUMAN; INTERVENTION STUDY; LUNG CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYMPTOM;

EID: 84861797776     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972312441632     Document Type: Review

References (52)

1. Ferrell B, Koczywas M, Grannis F, Harrington A. Palliative care in lung cancer. Surg Clin N Am. 2011 ; 91: 403-417
2. Schulte T, Schniewind B, Dohrmann P, Kuchler T, Kurdow R. The extent of lung parenchyma resection significantly impacts on long-term quality of life in patients with non-small cell lung cancer. Chest. 2009 ; 135: 322-329
3. Dudgeon DJ, Rosenthal S. Management of dyspnoea and cough patients with cancer. Hematol Oncol Clin N Am. 1996 ; 10: 157-171
4. Smith EL, Hann DM, Ahles TA, Furstenberg CT, Mitchell TA, Meyer L, et al. Dyspnoea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage. 2001 ; 21: 323-329
5. Irwin RS, French CT, Fletcher KE. Quality of life in coughers. Pulm Pharmacol Ther. 2002 ; 15: 283-286
6. Dyspnea: mechanisms, assessment and management: a consensus statement. Am J Respir Dis. 1991 ; 159: 321-340
7. Lutz S, Norrell R, Bertucio C, Kachnic L, Johnson C, Arthur D, et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital. J Palliat Med. 2001 ; 4: 157-165
8. Edmonds P, Higginson I, Altmann D, Sen-Gupta G, McDonnell M. Is the presence of dyspnea a risk factor for morbidity in cancer patients?. J Pain Symptom Manage. 2000 ; 19: 15-22
9. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Factors correlated with dyspnea in advanced lung cancer patients: organic causes and what else?. J Pain Symptom Manage. 2002 ; 23: 490-500
10. Bausewein C, Booth S, Gysels M, Higginson IJ. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008 ; 2: CD005623
11. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002 ; 57: 939-944
12. Higginson I, McCarthy M. Measuring symptoms in terminal cancer: are pain and dyspnoea controlled ?. J R Soc Med. 1989 ; 82: 264-267
13. Kvale PA. Chronic cough due to lung tumors. ACCP evidence-based clinical practice guidelines. Chest. 2003 ; 129: 147-153
14. Molassiotis A, Lowe M, Blackhall F, Lorigan P. A qualitative exploration of a respiratory distress symptom cluster in lung cancer: cough, breathlessness and fatigue. Lung Cancer. 2011 ; 71 (1). 94-102
15. French CL, Irwin RS, Curley FJ, Krikorian RN. Impact of chronic cough on quality of life. Arch Intern Med. 1998 ; 158: 1657-1661
16. Wang XS, Shi Q, Lu C, Basch EM, Johnson VE, Mendoza TR, et al. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced non-small cell lung cancer. Cancer. 2010 ; 116: 137-145
17. Homsi J, Walsh D, Nelson KA. Important drugs for cough in advanced cancer. Support Care Cancer. 2001 ; 9: 565-574
18. Molassiotis A, Bailey C, Caress A, Brunton L, Smith J. Interventions for cough in cancer. Cochrane Database Syst Rev. 2010 ; 9: CD007881
19. Molassiotis A, Lowe M, Ellis J, Wagland R, Bailey C, Lloyd-Williams M, et al. The experience of cough in patients diagnosed with lung cancer. Support Care Cancer. 2011 ; 19: 1997-2004
20. Homsi J, Walsh D, Nelson KA, Sarhill N, Rybicki L, LeGrand SB, et al. A phase II study of hydrocodone for cough in advanced cancer. Am J Hosp Palliat Care. 2002 ; 19: 49-56
21. Uzan O, Atasoy Y, Findik S, Atici AG, Erkan L. A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J. 2010 ; 4: 131-138
22. Hishberb B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997 ; 112: 440-444
23. Gift AG. Validation of a vertical visual analogue scale as a measure of clinical dyspnea. Rehabil Nurs. 1989 ; 14: 323-325
24. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998 ; 7: 200-204
25. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978 ; 1: 373-378
26. De Hass J, Olschewski M, Fayers P, Visser MRM, Cull A, Hopwood P The Rotterdam Symptom Checklist (RSCL): a manual. Groningen: Northern Centre for Healthcare Research, University of Groningen ; 1996 :
27. Barton R, English A, Nabb S, Rigby AS, Johnson MJ. A randomised trial of high vs low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer. 2010 ; 70: 313-319
28. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A'Hern R. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999 ; 318: 901-904
29. Chan CW, Richardson A, Richardson J. Managing symptoms in patients with advanced lung cancer during radiotherapy: results of a psychoeducational randomized controlled trial. J Pain Symptom Manage. 2011 ; 41: 347-357
30. Connors S, Graham S, Peel T, Connors S, Graham S, Peel T. An evaluation of a physiotherapy led non-pharmacological breathlessness programme for patients with intrathoracic malignancy. Palliat Med. 2007 ; 21: 285-287
31. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med. 1996 ; 10: 299-305
32. Filshie J, Penn K, Ashley S, Davis CL. Acupuncture for the relief of cancer-related breathlessness. Palliat Med. 1996 ; 10: 145-150
33. Hately J, Laurence V, Scott A, Baker R, Thomas P. Breathlessness clinics within specialist palliative care settings can improve the quality of life and functional capacity of patients with lung cancer. Palliat Med. 2003 ; 17: 410-417
34. McCorkle R, Benoliel J, Donaldson G, Georgiadou F, Moinpour C, Goodell BA. Randomized clinical trial of home nursing care for lung cancer patients. Cancer. 1998 ; 64: 1375-1382
35. Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, et al. Nurse led follow-up and conventional medical follow-up in management of patients with lung cancer: randomised trial. BMJ. 2002 ; 325: 1-7
36. Porter LS, Keefe FJ, Garst J, Baucom DH, McBride CM, McKee DC, et al. Caregiver-assisted coping skills training for lung cancer. Results of a RCT. J Pain Symptom Manage. 2011 ; 41: 11-13
37. Sarna J. Effectiveness of structured nursing assessment of symptom distress in advanced lung cancer. Oncol Nurs Forum. 1998 ; 25: 1041-1048
38. Skrutkowski M, Saucier M, Eades M, Swidzinski M, Ritchie J, Marchionni , et al. Impact of a pivot nurse in oncology patients with lung or breast cancer: symptoms, distress, fatigue, quality of life, and use of healthcare resources. Oncol Nurs Forum. 2008 ; 35: 948-954
39. Vickers AJ, Feinstein MB, Deng GE, Cassileth BR. Acupuncture for dyspnea in advanced cancer: a randomized, placebo-controlled pilot trial. BMC Palliat Care. 2005 ; 4: 5
40. Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995 ; 12: 199-220
41. Aaronson NK, Ahmedzai S, Bergman B. The European Organisation for Research and Treatment of Cancer QLQ30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 ; 85: 365-376
42. Guyat G, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987 ; 42: 773-778
43. Cohen J. A power primer. Psychol Bull. 1992 ; 112: 155-159
44. Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med. 2007 ; 21: 177-191
45. Molen B. Dyspnoea: a study of measurement instruments for the assessment of dyspnoea and their application for patients with advanced cancer. J Adv Nurs. 1995 ; 22: 948-956
46. Yorke J, Moosavi S, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax. 2010 ; 65: 21-26
47. Swigris J, Yorke J, Sprunger D, du Bois R, Fischer A. The impact of dyspnoea on patients with connective tissue disease-related ILD. Respir Med. 2010 ; 104: 1350-1355
48. Yorke J, Swigris J, Russell AM, Kwong G, Jones PW. Dyspnoea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011 ; 139: 159-164
49. Yorke J, Russell A, Swigris J, Shuldham C, Haigh C, Jones PW. Assessment of dyspnoea in asthma: validation of the Dyspnoea-12. J Asthma. 2011 ; 48: 602-608
50. Molassiotis A, Ellis J, Wagland R, Lloyd Williams M, Bailey CB, Booton R, et al. The Manchester Cough in Lung Cancer scale: the development and preliminary validation of a new assessment tool. J Pain Symptom Manage. (in press) ;:
51. Wagland R, Molassiotis A. How standard is 'standard care' in the symptom management of patients with lung cancer? The example of the 'respiratory distress' symptom cluster. Eur J Oncol Nurs. 2011 ; 15: 1-2
52. Wells M, Sarna L, Cooley ME, Brown JK, Chernecky C, Williams RD, et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs. 2007 ; 30: 45-55